Process Improvements, Technology And Talent Key To The Future Of Cell & Gene Therapy

We sat down with Wade Macedone, Chief Operating Officer at Andelyn Biosciences, to talk about how process improvement and operational excellence play an important role in the future of Cell & Gene Therapies.

Process improvement and operational excellence is important to all pharmaceutical manufacturing. But how is it even more critical in the cell and gene space?

Cell and Gene Therapies are still maturing as an industry and there has been an exceedingly large investment in the field over the last couple years to help develop enough manufacturing capacity to keep up with growing demands. As the industry matures over time, it will be necessary to streamline and harmonize manufacturing platforms to maximize facility utilization, improve yields, improve product robustness, and scale to commercial demand.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene